In this interview, Stephane Moreau (Shimadzu Europa) introduces the new Q-TOF LCMS-9030 instrument among other technologies available for automation and microsamping.
Find out more about the current research focuses at KCAS Bioanalytical & Biomarker Services and how the industry has evolved over the last 5–10 years in this interview with John Bucksath (KCAS).
A small implantable device using LEDs has been developed to treat bladder problems, with the potential to replace current medications and electronic stimulators.
Researchers at the Brigham Young University (London, UK) have developed a non-invasive, nanoPOTS method for monitoring cancer by measuring the proteins in circulating tumor cells from the blood.
In this interview, Lawrence Goodwin (KCAS, KS, USA) explains his passion for tandem technology, the portfolio of services that KCAS offers and the advantages and disadvantages of their key technologies chromatography and mass spectrometry.
Take our short survey on large molecule quantification by LC–MS.
View time: 2:29 mins
In this interview, Anne Kleinnijenhuis (Triskelion; Zeist, The Netherlands) describes his current research focus, key challenges he faces when utilizing LC–MS and what he believes the future holds for the technology.
At PRA Health Sciences, we recognize that the world of clinical development is complex and dynamic, and we’ve designed our bioanalytical laboratories to meet those challenges. Proactive and always looking to the future, we provide the technology, innovative approaches, and high scientific standards required to deliver industry-leading laboratory servic
Sanofi (Paris, France) have acquired Ablynx (Ghent, Belgium) for €3.9 billion, including Ablynx’s Nanobody® technology platform and late-stage caplacizumab treatment.